BEI
ONC

Benjamin Edwards Inc’s BeOne Medicines Ltd ONC Stock Holding History

Benjamin Edwards Inc’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Buy
786
+8
+1% +$2.36K ﹤0.01% 1338
2026
Q1 		$231K Buy
778
+88
+13% +$28.5K ﹤0.01% 1266
2025
Q4 		$210K Buy
690
+51
+8% +$16.7K ﹤0.01% 1252
2025
Q3 		$218K Buy
+639
New +$194K ﹤0.01% 1220

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Benjamin Edwards Inc's ONC Position: Q2 2026 in Review

Benjamin Edwards Inc increased its BeOne Medicines Ltd (ONC) stake by 1% in Q2 2026, buying an estimated $2.36K and bringing the position to 786 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #1338.

Benjamin Edwards Inc first reported a position in ONC in Q3 2025 and has held it in 4 quarters since. The position peaked at $231K in Q1 2026. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Benjamin Edwards Inc held 786 shares of BeOne Medicines Ltd worth $224K as of Q2 2026.
  • Benjamin Edwards Inc bought 8 BeOne Medicines Ltd shares in Q2 2026, an estimated $2.36K.
  • BeOne Medicines Ltd made up ﹤0.01% of Benjamin Edwards Inc's portfolio in Q2 2026, its #1338 holding.
  • Benjamin Edwards Inc first reported a position in BeOne Medicines Ltd in Q3 2025 and has held it in 4 quarters since.
  • Benjamin Edwards Inc's BeOne Medicines Ltd position peaked at $231K in Q1 2026.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.